Switzerland's Roche to buy InterMune, US-based developer of lung disease drugs, in $8.3B deal
BERLIN (AP) -- Swiss pharmaceutical company Roche says it will buy a California-based developer of treatments for lung diseases, InterMune Inc., in a deal worth $8.3 billion. Roche said Sunday the companies have reached an agreement under which Roche will ...
Mid-air collision in Switzerland leaves 6 seriously injured
GENEVA, Switzerland – A collision between two light aircraft in Switzerland on Sunday, August 24, has left 6 people with serious injuries, according to police. One of the planes crashed in a field in the canton of St Gallen. Local police cited by Swiss ...
